Community

Our community narratives are driven by numbers and valuation.

Value any stock for free in seconds

Get alerts and valuation updates

Participate in discussions

Weekly Picks

RenovoRx

Stock_Research_Today

Community Contributor

Revolutionizing Cancer Treatment

A Precision Approach to Hard-to-Treat Cancers RenovoRx, Inc. (Nasdaq: RNXT), based in Mountain View, California, is a clinical-stage biopharma company taking a new approach to cancer treatment.

View narrative

US$4.20

73.6% undervalued

371.30%

Revenue growth p.a.

17 days ago

Apple

Investingwilly

Community Contributor

Apple: A Dying Star with an Overpriced Valuation

Intro Apple Inc. (AAPL) has long been one of the most beloved stocks in the market, celebrated for its sleek products and loyal customer base.

View narrative

US$177.34

19.2% overvalued

14.68%

Revenue growth p.a.

2 days ago

Avino Silver & Gold Mines

Agricola

Community Contributor

Avino a case for USD$20 per share within 5 years (assuming $3,500 gold, $100 silver and $4 copper).

Full disclosure. I am a shareholder at the time of writing this.

View narrative

CA$26.79

86.0% undervalued

78.01%

Revenue growth p.a.

17 days ago

RENK Group

Chris1

Community Contributor

Riding the Defense Boom RENK Sees Revenue Climb at 15% CAGR by FY 2029

In a renewed political landscape where a Trump administration adopts a more interventionist stance toward Ukraine, the United States sharply increases its military aid—providing advanced tank transmissions, power packs, and suspension systems. This pivot alleviates initial concerns among European allies, but it simultaneously reinforces the imperative for Europe to shore up its own defense capabilities.

View narrative

€69.87

20.5% undervalued

15.00%

Revenue growth p.a.

18 days ago

Load previous narratives

Velocity Composites

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

US Onboarding And European Defense Expansion Will Drive Progress

Key Takeaways Expanding defense sector opportunities in North America and Europe could diversify revenue streams and increase earnings potential. Implementation of the Odoo-based MRP system standardizes operations and improves data management, enhancing operational efficiencies and net margins.

View narrative

UK£0.60

60.0% undervalued

13.19%

Revenue growth p.a.

15 days ago

Kirkland's

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

Beyond Deal Will Improve Balance Sheet While 39% Reactivation Lags

Key Takeaways Strategic partnerships and e-commerce improvements are expected to strengthen Kirkland’s financial position and support future revenue and margin growth. Reengaging core customers and optimizing product offerings are key strategies anticipated to enhance revenue and operational efficiency.

View narrative

US$2.00

39.5% undervalued

-2.12%

Revenue growth p.a.

15 days ago

S&W Seed

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

High Margin Biofuels And $25M Facility Will Face US Risks

Key Takeaways Streamlined operations and strategic partnerships improve financial flexibility and liquidity, positioning the company closer to profitability. Focus on high-margin crops and strategic licensing boosts revenue potential and expands market presence, supporting long-term growth.

View narrative

US$35.00

84.5% undervalued

-21.08%

Revenue growth p.a.

15 days ago

DarioHealth

AnalystConsensusTarget

Consensus Narrative from 3 Analysts

Twill Integration And GLP-1 Focus Will Expand Health Solutions

Key Takeaways DarioHealth is positioned for significant revenue growth through strategic integrations, rising demand for companion solutions, and expanding market reach via partnerships. Adoption of AI capabilities and cost management strategies enhance operational efficiency, retain users, and improve margins, aiding in the path to profitability.

View narrative

US$2.33

71.9% undervalued

21.54%

Revenue growth p.a.

15 days ago

Wisr

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

Loan Automation And Operational Efficiency Will Deliver Success

Key Takeaways Strong loan origination growth and strategic investments are expected to drive future revenue and profitability. Automation and operational improvements will enhance efficiencies, reducing costs and contributing to improved net margins.

View narrative

AU$0.09

66.7% undervalued

97.51%

Revenue growth p.a.

15 days ago

Straker

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

Verify AI And Swiftbridge Will Lower Costs Amid Translation Headwinds

Key Takeaways Leveraging AI and automation to reduce costs and enhance margins can significantly improve profitability and drive new revenue streams. Strategic integration with workplace tools and regulations offers growth opportunities in user base and high-value client sectors.

View narrative

AU$0.37

43.2% overvalued

-0.60%

Revenue growth p.a.

15 days ago

Longeveron

AnalystConsensusTarget

Consensus Narrative from 4 Analysts

ELPIS II And Alzheimer Programs Will Accelerate FDA Approval

Key Takeaways Successful trial enrollment and regulatory designations could accelerate Longeveron's market entry and future revenue growth through streamlined FDA pathways and partnerships. Cost-management strategies in 2024 are set to improve margins and support key clinical trials, enhancing long-term earnings prospects.

View narrative

US$8.88

84.2% undervalued

124.15%

Revenue growth p.a.

15 days ago

Checkit

AnalystConsensusTarget

Consensus Narrative from 1 Analyst

US Market Expansion And Cost Savings Will Secure Robust Performance

Key Takeaways Checkit's U.S. market expansion and focus on high-margin industries indicate potential for significant revenue growth and sustained profitability. Operational efficiency and cost reduction efforts suggest improved margins and an accelerated path to profitability, bolstering a stable revenue base.

View narrative

UK£0.22

38.6% undervalued

10.26%

Revenue growth p.a.

15 days ago

Starbreeze

AnalystConsensusTarget

Consensus Narrative from 2 Analysts

Upcoming Releases And Partnerships Will Expand Market Reach

Key Takeaways Strategic partnerships and diversification into new platforms are expected to drive player base growth and positively impact revenue and audience reach. Self-publishing and workforce optimization indicate improved net margins and long-term operational efficiency, supported by strong cash management and financial stability.

View narrative

SEK 0.34

37.4% undervalued

14.32%

Revenue growth p.a.

15 days ago

Community

Weekly Picks

Revolutionizing Cancer Treatment

Apple: A Dying Star with an Overpriced Valuation

Avino a case for USD$20 per share within 5 years (assuming $3,500 gold, $100 silver and $4 copper).

Riding the Defense Boom RENK Sees Revenue Climb at 15% CAGR by FY 2029

US Onboarding And European Defense Expansion Will Drive Progress

Beyond Deal Will Improve Balance Sheet While 39% Reactivation Lags

High Margin Biofuels And $25M Facility Will Face US Risks

Twill Integration And GLP-1 Focus Will Expand Health Solutions

Loan Automation And Operational Efficiency Will Deliver Success

Verify AI And Swiftbridge Will Lower Costs Amid Translation Headwinds

ELPIS II And Alzheimer Programs Will Accelerate FDA Approval

US Market Expansion And Cost Savings Will Secure Robust Performance

Upcoming Releases And Partnerships Will Expand Market Reach

Value any company in seconds

Popular companies

Community

Weekly Picks

Revolutionizing Cancer Treatment

Apple: A Dying Star with an Overpriced Valuation

Avino a case for USD$20 per share within 5 years (assuming $3,500 gold, $100 silver and $4 copper).

Riding the Defense Boom RENK Sees Revenue Climb at 15% CAGR by FY 2029

Community Investing Ideas

US Onboarding And European Defense Expansion Will Drive Progress

Beyond Deal Will Improve Balance Sheet While 39% Reactivation Lags

High Margin Biofuels And $25M Facility Will Face US Risks

Twill Integration And GLP-1 Focus Will Expand Health Solutions

Loan Automation And Operational Efficiency Will Deliver Success

Verify AI And Swiftbridge Will Lower Costs Amid Translation Headwinds

ELPIS II And Alzheimer Programs Will Accelerate FDA Approval

US Market Expansion And Cost Savings Will Secure Robust Performance

Upcoming Releases And Partnerships Will Expand Market Reach

Value any company in seconds

Popular companies